Display Settings:

Format

Send to:

Choose Destination
    Clin Pharmacol Ther. 2010 Jul;88(1):135-7. Epub 2010 Jun 9.

    Next-generation model-based drug discovery and development: quantitative and systems pharmacology.

    Source

    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA. sandra.allerheiligen@merck.com

    Abstract

    Pharmaceutical researchers have undertaken many initiatives and technologies to stem the rising costs of drug discovery and development. Biomarkers, adaptive trial designs, modeling, trial simulations, predictive metabolism, data mining, and disease models have reshaped the way in which researchers approach discovery and development. Quantitative pharmacology (QP), which leverages model-based approaches, operates at both cultural and technical levels to integrate data and scientific disciplines so as to utilize existing knowledge while concomitantly enhancing the ability to make predictions about future experiments and results.

    PMID:
    20531467
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk